Skip to search formSkip to main contentSkip to account menu

Neulasta

National Institutes of Health

Related topics

Related topics

2 relations
0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe [Neulasta]

Broader (1)

pegfilgrastim

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract P4-12-07: Cost-minimization of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar ZARXIO® over NEUPOGEN®, NEULASTA®, and NEULASTA/ONPRO®: Breast cancer case study
RATIONALE & OBJECTIVES: Biosimilar filgrastim may offer significant cost advantages over originator filgrastim and pegfilgrastim… 
2018
2018
Novosti u prevenciji febrilne neutropenije - Neulasta Onpro Novelties in the prevention of febril neutropeniae - Neulasta Onpro
Neulasta je najučinkovitija u prevenciji nastanka febrilne neutropenije kod pacijenta, i to kada se lijek primjenjuje dan poslije… 
2017
2017
Abstract P5-11-07: Pharmacokinetics of eflapegrastim in a phase 2 open-label dose-ranging study in breast cancer patients receiving TC regimen
Background: Eflapegrastim (SPI-2012/HM10460A) is a novel, long acting recombinant human granulocyte colony-stimulating factor… 
2017
2017
Abstract P5-11-08: Immunogenicity of eflapegrastim in a phase 2 open-label dose-ranging study of eflapegrastim in breast cancer patients receiving TC regimen
Background : Eflapegrastim (SPI-2012/HM10460A) is a novel, long-acting recombinant human granulocyte colony-stimulating factor… 
2017
2017
Abstract P2-11-05: Safety, immunogenicity and efficacy of proposed biosimilar pegfilgrastim (LA-EP2006) compared with reference pegfilgrastim in breast cancer: Pooled analysis of two randomized…
Background: Biosimilars are highly similar to a biological reference product with no clinically meaningful differences in terms… 
2013
2013
Filgrastim (Neupogen®) y pegfilgrastim (Neulasta®) están asociados con un riesgo de síndrome de fuga capilar
Review
2013
Review
2013
Monsanto buys microbes
volume 31 number 4 aPrIl 2013 nature biotechnology They will continue to be. Further adjustments and friction are likely as… 
2005
2005
Big biotech embraces direct-to-consumer advertising
Under the gun of increased oversight on drug company advertising by the US Food and Drug Administration, the Washington, DC-based… 
2004
2004
Neulasta is a solution for injection containing pegfilgrastim. Pegfilgrastim, is a covalent conjugate of recombinant human Granulocyte-Colony Stimulating Factor (r-met-HuG-CSF, filgrastim) with a…
  • 2004
  • Corpus ID: 1881867
Pegfilgrastim and filgrastim belong to the class of haematopoietic growth factors (granulocyte-colony stimulating factor; G-CSF… 
2002
2002
Pegfilgrastim (Neulasta) for prevention of febrile neutropenia.